|
Market Closed -
Euronext Paris
19:55:00 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.7510 EUR | -2.47% |
|
-3.72% | +8.21% |
| 07-22 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 06-29 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
Evolution of the Average Target: Valbiotis
Evolution of the Target Price: Valbiotis
Changes in Analyst Recommendations: Valbiotis
8cfd24a0.R3OuZAkw4UXoEPxFXhlTgkL-o1s8pJ5D4-6xdzg6X10.AArGMUNRsQTbIr8ibSo4wAu78hoE1a4Jh7SGAFRJKhJwPtsmT36HLqlfyA~0e9d40350249330014daa8459483ca9f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +133.77% | ||||
| +16.56% | ||||||
| +18.28% | ||||||
| +60.95% | ||||||
| +16.05% | ||||||
| +20.37% | ||||||
| +9.35% | ||||||
| +16.93% | ||||||
| -8.21% | ||||||
| +64.19% | ||||||
| Average | +34.82% | |||||
| Weighted average by Cap. | +22.23% |


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7510EUR
Average target price
1.800EUR
Spread / Average Target
+139.68%
High Price Target
1.800EUR
Spread / Highest target
+139.68%
Low Price Target
1.800EUR
Spread / Lowest Target
+139.68%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ALVAL Stock
- Consensus Valbiotis
Select your edition
All financial news and data tailored to specific country editions
















